Innovation & Enterprise


UCL spinout Odin Vision receives funding to accelerate detection of bowel cancer

10 September 2020

Odin Vision has been awarded £1 million UK Government funding. This will support further testing and development of its artificial intelligence (AI) technology, which helps doctors detect and characterise early signs of bowel cancer.

A doctor watching a colonoscopy on a computer monitor

The funding, from NIHR (National Institute for Health Research), is part of a new programme to accelerate the testing of cutting-edge AI technologies in the NHS.

Odin Vision’s pioneering AI system is based on the academic research of UCL AI experts, led by Professor Danail Stoyanov (UCL Computer Science and Wellcome / EPSRC Centre for Interventional and Surgical Sciences at UCL).

Detecting bowel cancer using traditional colonoscopy methods can be challenging and up to 25% of polyps are missed. Odin Vision’s AI system identifies and characterises polyps by analysing live colonoscopy video, leading to early treatment of bowel cancer and saving lives. It will be used in a number of UK hospitals to test its impact on patient outcomes and cost benefits to the NHS.

Odin Vision has previously received support from the UCL Technology Fund (UCLTF). It was also one of the first UCL spinouts to benefit from Portico Ventures, a commercialisation model from UCL Business (UCLB), part of UCL Innovation & Enterprise. Portico Ventures aims to give UCL researchers more freedom to take their ideas to market through spinouts.

Read the full story on the UCL News website.


Find out more about:

Photo © Odin Vision